Clinical Trial Update: Effect of ADT and ARPI on Bone Loss of Patients with Prostate Cancer

View source ↗

Summary

Clinical trial update examining the effects of androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPI) on bone loss in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Prostate Cancer (Adenocarcinoma) | Status: NOT_YET_RECRUITING